Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 Opinion of Goodwin Procter LLP
- 10.3 Form of Subscription Agreement
- 10.6 Distribution Agreement, Dated June 25, 2018, by and Between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc
- 10.6 First Amendment to Distribution Agreement, Dated October 2, 2019, by and Between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc
- 10.6 Second Amendment to Distribution Agreement, Effective As of February 16, 2021, by and Between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc
- 10.7 Exclusive License Agreement, Dated February 25, 2014, by and Between Yale University and Humacyte, Inc
- 10.8 Exclusive License Agreement, Dated August 13, 2019, by and Between Yale University and Humacyte, Inc
- 10.9 Exclusive License Agreement, Dated August 25, 2019, by and Between Yale University and Humacyte, Inc
- 10.10 Exclusive Patent License Agreement, Dated March 14, 2006, Between Duke University and Humacyte, Inc
- 10.10 First Amendment to Exclusive Patent License Agreement, Dated February 25, 2011, Between Duke University and Humacyte, Inc.
- 10.10 Second Amendment to Exclusive Patent License Agreement, Dated April 24, 2014, Between Duke University and Humacyte, Inc
- 10.10 Third Amendment to Exclusive Patent License Agreement, Dated June 26, 2015, Between Duke University and Humacyte, Inc
- 10 Fourth Amendment to Exclusive Patent License Agreement, Dated January 2, 2018, Between Duke University and Humacyte, Inc
- 10.10 Fifth Amendment to Exclusive Patent License Agreement, Dated December 31, 2019, Between Duke University and Humacyte, Inc
- 10.11 Supply Agreement, Dated January 9, 2014, Between Seracare Life Sciences, Inc. and Humacyte, Inc
- 10.11 First Amendment to Supply Agreement, Dated October 12, 2018, Between Seracare Life Sciences, Inc. and Humacyte, Inc
- 10.12 Supply Agreement, Dated August 31, 2015, Between Confluent Medical Technologies (Formerly Known As Biomedical Structures LLC) and Humacyte, Inc
- 10.13 Executive Employment Agreement, Dated February 3, 2021, Between Laura Niklason, M.D., PH.D. and Humacyte, Inc
- 10.14 Executive Employment Agreement, Dated June 19, 2018, Between Jeffrey Lawson, M.D. and Humacyte, Inc
- 10.14 Amendment to Executive Employment Agreement, Dated February 3, 2021, Between Jeffrey Lawson, M.D. and Humacyte, Inc
- 10.15 Executive Employment Agreement, Dated October 8, 2018, Between Douglas Blankenship and Humacyte, Inc
- 10.16 Executive Employment Agreement, Dated September 13, 2019, Between Heather Prichard, PH.D. and Humacyte, Inc
- 10.18 Humacyte, Inc. 2005 Stock Option Plan
- 10.18 First Amendment of Humacyte, Inc. 2005 Stock Option Plan, Dated March 31, 2008
- 10.18 Second Amendment of Humacyte, Inc. 2005 Stock Option Plan, Dated October 28, 2011
- 10.18 Third Amendment of Humacyte, Inc. 2005 Stock Option Plan, Dated November 22, 2013
- 10.18 Form of Incentive Stock Option Agreement Under Humacyte, Inc. 2005 Stock Option Plan
- 10.18 Form of Nonstatutory Stock Option Agreement Under Humacyte, Inc. 2005 Stock Option Plan
- 10.19 Humacyte, Inc. 2015 Omnibus Incentive Plan
- 10.19 First Amendment to Humacyte, Inc. 2015 Omnibus Incentive Plan, Dated February 23, 2018
- 10.19 Second Amendment to Humacyte, Inc. 2015 Omnibus Incentive Plan, Dated June 6, 2018
- 10.19 Form of Incentive Stock Option Agreement Under Humacyte, Inc. 2015 Omnibus Incentive Plan
- 10.19 Form of Nonstatutory Stock Option Agreement Under Humacyte, Inc. 2015 Omnibus Incentive Plan
- 10.20 Annual Bonus Plan
- 10.22 Lease Agreement, Dated December 31, 2015, Between Are-nc Region No. 5, LLC and Humacyte, Inc
- 10.22 First Amendment to Lease, Dated September 30, 2016, Between Are-nc Region No. 5, LLC and Humacyte, Inc
- 10.22 Second Amendment to Lease, Dated February 8, 2017, Between Are-nc Region No. 5, LLC and Humacyte, Inc
- 10.22 Third Amendment to Lease, Dated April 21, 2017, Between Are-nc Region No. 5, LLC and Humacyte, Inc
- 10.22 Fourth Amendment to Lease, Dated October 31, 2017, Between Are-nc Region No. 5, LLC and Humacyte, Inc
- 21.1 Subsidiaries of Alpha Healthcare Acquisition Corp
- 23.2 Consent of Marcum LLP
- 23.3 Consent of Pricewaterhousecoopers LLP
- 99.3 Consent of Laura E. Niklason, M.D., PH.D
- 99.4 Consent of Brady W. Dougan
- 99.5 Consent of Emery N. Brown, M.D., PH.D
- 99.6 Consent of Kathleen Sebelius
- 99.7 Consent of Max Wallace, J.D
- 99.8 Consent of Susan Windham-bannister, PH.D
Associated filings
- 5 Aug 21 EFFECT Notice of effectiveness
- 4 Aug 21 424B3 Prospectus supplement
- 2 Aug 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 1 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 14 Jun 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
23 Mar 21 S-4 Registration of securities issued in business combination transactions
HUMA similar filings
- 23 Jul 21 Registration of securities issued in business combination transactions (amended)
- 1 Jul 21 Registration of securities issued in business combination transactions (amended)
- 14 Jun 21 Registration of securities issued in business combination transactions (amended)
- 23 Mar 21 Registration of securities issued in business combination transactions
Filing view
External links